Median Technologies (XPAR:ALMDT) Dividend Yield %: 0.00% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALMDT Median Technologies XPAR:ALMDT
49 GF Score
Price €4.11
GF Value €1.73
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Median Technologies Dividend Yield %?

Median Technologies XPAR:ALMDT -3.75% 49 Dividend Yield % is 0.00% as of Jul. 18, 2026. GuruFocus rates XPAR:ALMDT with a GF Score™ of 49/100 and a GF Value™ of €1.73 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 325 Medical Devices & Instruments companies, Median Technologies ranks worse than 307692% on this metric.

As of today (2026-07-18), the Trailing Annual Dividend Yield of Median Technologies is 0.00%.

The historical rank and industry rank for Median Technologies's Dividend Yield % or its related term are showing as below:

XPAR:ALMDT's Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.98
* Ranked among companies with meaningful Dividend Yield % only.

Median Technologies's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-07-18), the Forward Dividend Yield % of Median Technologies is 0.00%.

Median Technologies's Dividends per Share for the six months ended in Dec. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Median Technologies  (XPAR:ALMDT) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Median Technologies Dividend Yield % Related Terms


Median Technologies Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Median Technologies's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Technologies Dividend Yield % Chart

Median Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Median Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XPAR:ALMDT vs ABT, SYK, MDT: Dividend Yield % Comparison

For the Medical Devices subindustry, Median Technologies's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Technologies Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Median Technologies's Dividend Yield % falls into.


XPAR:ALMDT
49GF Score
Median Technologies XPAR:ALMDT
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Median Technologies Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Median Technologies (XPAR:ALMDT) has a Dividend Yield % of 0.00% as of Jul. 18, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Median Technologies and its competitors. According to the industry distribution chart, Median Technologies ranks #999999 out of 325 companies in the Medical Devices & Instruments industry.
Is Median Technologies' Dividend Yield % too high?
Median Technologies' current Dividend Yield % is 0.00%. Based on the distribution chart, Median Technologies ranks #999999 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Median Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Median Technologies' Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Median Technologies ranks #999999 out of 325 companies for Dividend Yield %. This places Median Technologies in the lower half of its industry. The industry median Dividend Yield % is 1.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Median Technologies and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Median Technologies's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Median Technologies stock overvalued right now?
Based on GuruFocus' analysis, Median Technologies (XPAR:ALMDT) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.73, compared to a current price of €4.11 — trading 137.6% above its estimated fair value. The current Dividend Yield % is 0.00%. Median Technologies' overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Median Technologies (XPAR:ALMDT), the current Dividend Yield % is 0.00% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Median Technologies (XPAR:ALMDT) Overvalued in 2026?

Based on GuruFocus' analysis, Median Technologies stock appears to be overvalued. The current stock price of €4.11 is trading 137.6% above its estimated GF Value™ of €1.73. GuruFocus considers Median Technologies to be Significantly Overvalued.

Key valuation signals for XPAR:ALMDT:

  • Dividend Yield %: 0.00%
  • GF Value™: €1.73 vs. price of €4.11 (137.6% above fair value)
  • GF Score™: 49/100 with 8 warning signs

No single metric tells the full story. See the XPAR:ALMDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Median Technologies Business Description

Other Exchanges 4ZG:Germany
Address 1800 Route Des Cretes, Les Deux Arcs, Building B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
49GF Score

Get the complete analysis for XPAR:ALMDT

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.11
Price
€1.73
GF Value